Etienne Garin
7PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 16, 2026
Machine learning models classifiers enable a strong prediction of radioembolization-induced liver disease, and define a new bilirubin threshold for selection of patients.Itzel Rivera, Heloïse Bourien, Ewan Morel-Corlu
|Jul 28, 2023
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials.Julien Edeline, John Bridgewater, Boris Campillo-Gimenez
|Aug 18, 2022
Trans-arterial Radioembolization Dosimetry in 2022.Etienne Garin, Boris Guiu, Julien Edeline
|Sep 20, 2021
Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.Mary F Mulcahy, Armeen Mahvash, Marc Pracht
|Feb 05, 2019
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization.Kostas Delaunay, Julien Edeline, Yan Rolland
|Mar 22, 2018
A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy.Vincent Manceau, Xavier Palard, Yan Rolland
Pageof 2
Frequent Collaborators
2 joint publications
Julien Edeline
2 joint publications
Yan Rolland
1 joint publications
Mary F Mulcahy
1 joint publications
Armeen Mahvash
1 joint publications
Marc Pracht
1 joint publications
Steve Bandula
1 joint publications
Ewan Brown
1 joint publications
Constantinos T Sofocleous
1 joint publications
Riad Salem
1 joint publications
John Bridgewater
